Published in Vaccines (Basel) on December 09, 2015
Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet (1982) 4.56
Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis (1974) 4.41
Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ (1994) 4.10
Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet (1987) 3.91
Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol (1993) 2.85
Rubella. Lancet (2004) 2.57
Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology (2006) 2.36
Mumps outbreaks across England and Wales in 2004: observational study. BMJ (2005) 1.87
The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiol Infect (2000) 1.86
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis (2007) 1.79
Mumps and the UK epidemic 2005. BMJ (2005) 1.74
Chickenpox in adults - clinical management. J Infect (2008) 1.70
Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med (1966) 1.66
Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol (2003) 1.61
Rubella. Semin Fetal Neonatal Med (2007) 1.58
Mumps and mumps vaccine: a global review. Bull World Health Organ (1999) 1.53
An epidemiologic study of mumps; its spread in schools and families. Am J Hyg (1962) 1.52
Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Virol (1988) 1.50
Frequency of defects in infants whose mothers had rubella during pregnancy. J Am Med Assoc (1957) 1.49
Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City. Vaccine (2013) 1.44
Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis (2008) 1.42
Epidemiology of rubella. Am J Dis Child (1969) 1.38
The history and medical consequences of rubella. Rev Infect Dis (1985) 1.38
A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health (2001) 1.37
Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis (2011) 1.31
Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test. Pediatrics (1975) 1.27
Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect (2004) 1.26
Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay. Clin Vaccine Immunol (2006) 1.20
Isolation of mumps virus from human beings with induced apparent or inapparent infections. J Exp Med (1948) 1.20
Mumps in a general population. A sero-epidemiologic study. Am J Dis Child (1970) 1.19
Rubella in Europe. Epidemiol Infect (1991) 1.18
Identification of the rubella virus nonstructural proteins. Virology (1995) 1.17
Rubella. Lancet (2015) 1.16
Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study. Occup Environ Med (2000) 1.14
Improving sensitivity of oral fluid testing in IgG prevalence studies: application of mixture models to a rubella antibody survey. Epidemiol Infect (2003) 1.14
Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men. J Clin Virol (2013) 1.14
Confirmation of rubella within 4 days of rash onset: comparison of rubella virus RNA detection in oral fluid with immunoglobulin M detection in serum or oral fluid. J Clin Microbiol (2008) 1.12
The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev (1997) 1.10
Rubella eradication. Vaccine (2001) 1.10
Polypeptides of mumps virus. J Virol (1976) 1.09
Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy. Epidemiol Rev (2002) 1.09
An RT-PCR assay using oral fluid samples to detect rubella virus genome for epidemiological surveillance. Mol Cell Probes (2002) 1.07
Rubella vaccines: past, present and future. Epidemiol Infect (1991) 1.07
An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community. Trans R Soc Trop Med Hyg (1999) 1.07
Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect (2012) 1.06
Status of global virologic surveillance for rubella viruses. J Infect Dis (2011) 1.06
Novel methods for the detection of microbial antibodies in oral fluid. Lancet Infect Dis (2002) 1.05
Salivary diagnosis of rubella: a study of notified cases in the United Kingdom, 1991-4. Epidemiol Infect (1998) 1.05
Rescue of mumps virus from cDNA. J Virol (2000) 1.03
Serological study of rubella-like illnesses. J Med Virol (1987) 1.03
Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012. Emerg Infect Dis (2014) 1.02
Vaccination to prevent varicella and shingles. J Clin Pathol (2001) 1.02
Salivary antibody detection in epidemiological surveys: a pilot study after a mass vaccination campaign against rubella in São Paulo, Brazil. Trans R Soc Trop Med Hyg (1995) 1.02
Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J Clin Microbiol (2008) 1.02
Live attenuated vaccines: Historical successes and current challenges. Virology (2015) 1.00
Genetic diversity of mumps virus in oral fluid specimens: application to mumps epidemiological study. J Infect Dis (2004) 0.99
Viral causes of hearing loss: a review for hearing health professionals. Trends Hear (2014) 0.99
HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection. J Am Pharm Assoc (2003) (2014) 0.98
Improving global virologic surveillance for measles and rubella. J Infect Dis (2011) 0.97
A comparison of oral fluid and serum for the detection of rubella-specific antibodies in a community study in Addis Ababa, Ethiopia. Trop Med Int Health (1998) 0.96
Comparison of varicella history with presence of varicella antibody in refugees. Vaccine (2004) 0.95
Molecular biology, pathogenesis and pathology of mumps virus. J Pathol (2015) 0.95
Oral fluid testing during 10 years of rubella elimination, England and Wales. Emerg Infect Dis (2010) 0.94
Determination of measles, mumps, and rubella immunization status using oral fluid samples. JAMA (1994) 0.94
Observations on a mumps epidemic in a virgin population. Am J Hyg (1959) 0.94
Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy. J Clin Pathol (2002) 0.93
Detection of rubella virus-specific immunoglobulin G in saliva by an amplification-based enzyme-linked immunosorbent assay using monoclonal antibody to fluorescein isothiocyanate. J Clin Microbiol (1999) 0.93
Analysis of whole genome sequences of 16 strains of rubella virus from the United States, 1961-2009. Virol J (2013) 0.93
Oral fluid human immunodeficiency virus tests: improved access to diagnosis for infants in poorly resourced prevention of mother to child transmission programs. Pediatr Infect Dis J (2005) 0.93
Real-time PCR and its application to mumps rapid diagnosis. J Med Virol (2007) 0.92
The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella. Bull World Health Organ (2002) 0.92
Cryo-electron tomography of rubella virus. J Virol (2012) 0.92
Phylogenetic analysis of rubella viruses involved in congenital rubella infections in France between 1995 and 2009. J Clin Microbiol (2010) 0.91
Application of molecular and serological assays to case based investigations of rubella and congenital rubella syndrome. J Med Virol (2007) 0.90
Assessment of serological evidence for mumps virus infection in vaccinated children. Vaccine (2011) 0.89
Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection. J Virol Methods (2009) 0.89
Surveillance of measles in England and Wales: implications of a national saliva testing programme. Bull World Health Organ (1997) 0.89
Seroprevalence of varicella antibodies in healthcare workers and health sciences students. Reliability of self-reported history of varicella. Vaccine (2005) 0.88
Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts. Eur J Clin Microbiol Infect Dis (2008) 0.88
Recommendations from an ad hoc Meeting of the WHO Measles and Rubella Laboratory Network (LabNet) on use of alternative diagnostic samples for measles and rubella surveillance. MMWR Morb Mortal Wkly Rep (2008) 0.87
Varicella and the pregnant woman: prevention and management. Aust N Z J Obstet Gynaecol (2008) 0.87
Time-resolved fluorometric immunoassay for rubella antibody--a useful method for serosurveillance studies. Vaccine (2002) 0.86
Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults. Paediatr Perinat Epidemiol (2011) 0.86
New preventive strategy to eliminate measles, mumps and rubella from Europe based on the serological assessment of herd immunity levels in the population. Eur J Clin Microbiol Infect Dis (2013) 0.85
Reliability of varicella history in children and adolescents. Swiss Med Wkly (2005) 0.83
Evaluation of a commercial assay for the detection of mumps specific IgM antibodies in oral fluid and serum specimens. J Clin Virol (2005) 0.83
Mumps: a resurgent disease with protean manifestations. Med J Aust (2008) 0.83
Resurgence of mumps in Korea. Infect Chemother (2015) 0.83
Epidemiologic and diagnostic evaluation of a recent mumps outbreak using oral fluid samples. J Clin Virol (2008) 0.82
Evaluation of a commercial rubella IgM assay for use on oral fluid samples for diagnosis and surveillance of congenital rubella syndrome and postnatal rubella. J Clin Virol (2006) 0.81
How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age. Int J Infect Dis (2003) 0.81
Participant-collected, mail-delivered oral fluid specimens can replace traditional serosurveys: a demonstration-of-feasibility survey of hepatitis A virus-specific antibodies in adults. Can J Public Health (2007) 0.81
Reported exposure to chickenpox: a predictor of positive anti-varicella-zoster antibodies in parturient women. Fetal Diagn Ther (2001) 0.81
Evaluation of the CDC proposed laboratory HIV testing algorithm among men who have sex with men (MSM) from five US metropolitan statistical areas using specimens collected in 2011. J Clin Virol (2013) 0.81
Serotesting versus presumptive varicella vaccination of adolescents with a negative or uncertain history of chickenpox. J Adolesc Health (2001) 0.81
The eradication of rubella. JAMA (1999) 0.81
Development and evaluation of a rapid immunochromatographic test for mumps-specific IgM in oral fluid specimens and use as a matrix for preserving viral nucleic acid for RT-PCR. J Med Virol (2010) 0.80
Could oral fluid be used to evaluate anti-hepatitis A virus status in individuals living in difficult-to-access areas? Vaccine (2012) 0.79
Application of new assays for rapid confirmation and genotyping of isolates of rubella virus. J Med Virol (2011) 0.79
Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C. J Clin Microbiol (1992) 0.78